The Latest Analyst Ratings For Ovid Therapeutics
The Latest Analyst Ratings For Ovid Therapeutics
Ovid Therapeutics的最新分析師評級
Ratings for Ovid Therapeutics (NASDAQ:OVID) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 8 | 0 | 2 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 3 | 0 | 1 | 0 | 0 |
| 3M Ago | 3 | 0 | 1 | 0 | 0 |
Analysts have recently evaluated Ovid Therapeutics and provided 12-month price targets. The average target is $4.87, accompanied by a high estimate of $9.00 and a low estimate of $1.20. This current average represents a 24.38% decrease from the previous average price target of $6.44.
Exploring Analyst Ratings: An In-Depth Overview
The perception of Ovid Therapeutics by financial experts is...
登入免費觀看全文
登入/註冊